Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › LOS ANGELES › COUNTY OF LOS ANGELES

COUNTY OF LOS ANGELES

NPI: 1336279959 · LOS ANGELES, CA 90033 · General Acute Care Hospital · NPI assigned 03/06/2007

$8.79M
Total Medicaid Paid
279,717
Total Claims
241,157
Beneficiaries
202
Codes Billed
2018-01
First Month
2024-09
Last Month

Provider Details

Authorized OfficialOROZCO, JORGE (CHIEF EXECUTIVE OFFICER)
NPI Enumeration Date03/06/2007

Related Entities

Other providers sharing the same authorized official: OROZCO, JORGE

ProviderCityStateTotal Paid
COUNTY OF LOS ANGELES LOS ANGELES CA $216.55M
COUNTY OF LOS ANGELES LOS ANGELES CA $63.83M
COUNTY OF LOS ANGELES LOS ANGELES CA $19.75M
COUNTY OF LOS ANGELES LOS ANGELES CA $1.24M
COUNTY OF LOS ANGELES LOS ANGELES CA $306K
COUNTY OF LOS ANGELES LOS ANGELES CA $26K
COUNTY OF LOS ANGELES LOS ANGELES CA $2K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 151,120 $2.67M
2019 81,940 $1.99M
2020 9,070 $131K
2021 12,485 $1.83M
2022 11,663 $1.66M
2023 12,366 $486K
2024 1,073 $15K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
0111 307 289 $3.40M
0450 Emergency room services 32,960 28,794 $1.32M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 12,726 10,490 $390K
74174 1,641 1,510 $356K
99205 Prolong outpt/office vis 2,289 1,973 $303K
70450 Computed tomography, head or brain; without contrast material 2,916 2,684 $260K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 10,298 8,734 $188K
0200 15 13 $187K
99281 Emergency department visit for the evaluation and management, self-limited or minor 10,032 8,408 $185K
G0378 Hospital observation service, per hour 809 458 $164K
99215 Prolong outpt/office vis 1,185 957 $161K
72125 Computed tomography, cervical spine; without contrast material 965 904 $125K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,495 6,264 $110K
0510 4,486 3,798 $101K
71260 Computed tomography, thorax, diagnostic; with contrast material 589 562 $93K
99283 Emergency department visit for the evaluation and management, moderate severity 2,051 1,929 $75K
0250 23,330 18,234 $69K
80048 Basic metabolic panel (calcium, ionized) 11,907 10,189 $66K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 13,285 11,408 $65K
99199 Unlisted special service, procedure or report 877 829 $60K
71046 Radiologic examination, chest; 2 views 3,534 3,191 $48K
70486 377 349 $42K
71045 Radiologic examination, chest; single view 5,926 5,430 $42K
J7030 Infusion, normal saline solution , 1000 cc 6,419 5,344 $39K
80076 7,581 6,648 $38K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,386 2,863 $36K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,585 1,442 $34K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,513 1,376 $33K
84484 4,177 3,489 $30K
99221 3,299 2,719 $28K
J1953 Injection, levetiracetam, 10 mg 120 104 $27K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,886 1,765 $27K
83690 5,285 4,639 $22K
80053 Comprehensive metabolic panel 2,580 2,330 $19K
83605 2,515 2,097 $19K
76700 Ultrasound, abdominal, real time with image documentation; complete 319 286 $18K
83880 1,043 889 $17K
76705 Ultrasound, abdominal, real time with image documentation; limited 435 390 $17K
73564 762 690 $17K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 292 286 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 305 274 $15K
73610 785 710 $15K
85610 5,763 5,133 $15K
93971 213 179 $14K
73110 658 597 $12K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,102 1,876 $11K
73030 569 526 $11K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 500 440 $11K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 459 338 $11K
86703 1,373 1,267 $11K
80047 2,028 1,808 $11K
73080 475 426 $10K
73590 608 559 $10K
87040 805 701 $9K
J0696 Injection, ceftriaxone sodium, per 250 mg 931 820 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 510 445 $9K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,777 1,523 $9K
73090 552 487 $9K
86850 2,429 2,183 $9K
80306 360 338 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 253 229 $8K
87522 Neg quan hep c or qual rna 345 319 $8K
76801 184 151 $8K
99284 Emergency department visit for the evaluation and management, high severity 220 217 $8K
82550 1,548 1,274 $8K
87088 1,963 1,734 $7K
73130 411 372 $7K
74177 Computed tomography, abdomen and pelvis; with contrast material 178 174 $7K
J2250 Injection, midazolam hydrochloride, per 1 mg 671 610 $7K
99217 47 46 $7K
86901 2,602 2,260 $6K
73630 378 353 $6K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 275 268 $6K
81000 3,191 2,806 $6K
0255 107 106 $6K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 358 321 $6K
81025 2,033 1,742 $6K
81001 3,072 2,677 $6K
0761 470 390 $5K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 363 328 $5K
0516 188 170 $5K
73120 410 380 $5K
86900 2,591 2,250 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 516 507 $5K
73620 395 355 $5K
99218 84 82 $5K
86141 771 671 $5K
85730 1,271 1,162 $5K
84703 1,043 900 $5K
94760 615 548 $5K
J0780 Injection, prochlorperazine, up to 10 mg 412 380 $5K
J1630 Injection, haloperidol, up to 5 mg 1,027 888 $5K
71275 Computed tomographic angiography, chest, with contrast material 30 26 $4K
0760 289 224 $4K
J2060 Injection, lorazepam, 2 mg 882 741 $4K
70498 25 25 $4K
J7120 Ringers lactate infusion, up to 1000 cc 636 562 $4K
83036 Hemoglobin; glycosylated (A1C) 602 573 $3K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 597 520 $3K
85027 808 726 $3K
36415 Collection of venous blood by venipuncture 10,419 8,814 $3K
J1170 Injection, hydromorphone, up to 4 mg 540 417 $3K
80061 Lipid panel 357 339 $3K
S0077 Injection, clindamycin phosphate, 300 mg 137 94 $3K
80305 489 399 $3K
72100 142 127 $3K
81015 1,445 1,374 $3K
87070 485 406 $3K
J8540 Dexamethasone, oral, 0.25 mg 216 161 $3K
87210 869 780 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 104 101 $2K
J2270 Injection, morphine sulfate, up to 10 mg 583 478 $2K
J3010 Injection, fentanyl citrate, 0.1 mg 595 548 $2K
73060 146 129 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 628 549 $2K
72170 153 134 $2K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 76 72 $2K
87536 62 59 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 137 130 $2K
87186 396 346 $2K
82962 1,279 1,094 $2K
93041 273 182 $2K
J3475 Injection, magnesium sulfate, per 500 mg 197 168 $2K
73502 84 71 $2K
97161 73 72 $2K
81002 1,286 1,093 $2K
77067 Screening mammography, bilateral, including computer-aided detection 29 29 $2K
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 704 531 $2K
73552 96 90 $2K
83026 872 789 $2K
J7050 Infusion, normal saline solution, 250 cc 731 564 $1K
83735 303 230 $1K
90999 Unlisted dialysis procedure, inpatient or outpatient 62 59 $1K
82140 184 167 $1K
86592 502 471 $1K
73562 53 50 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg 359 316 $1K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 687 595 $1K
76870 33 28 $1K
84439 212 198 $1K
88182 39 37 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg 236 195 $941.66
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 155 142 $895.33
84100 282 217 $889.17
87340 179 164 $881.94
J1940 Injection, furosemide, up to 20 mg 117 87 $832.55
90792 Psychiatric diagnostic evaluation with medical services 14 14 $758.69
59025 Fetal non-stress test 16 13 $755.70
J3370 Injection, vancomycin hcl, 500 mg 72 53 $737.45
99222 Initial hospital care, per day, moderate complexity 13 12 $724.70
85378 155 137 $724.50
J7510 Prednisolone oral, per 5 mg 168 152 $715.30
86593 314 296 $706.92
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 13 13 $681.40
86480 25 24 $665.93
87086 Culture, bacterial; quantitative colony count, urine 158 149 $661.75
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 97 82 $656.94
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 87 85 $648.07
76770 14 13 $595.74
84702 56 54 $562.44
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 477 421 $547.90
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 14 14 $488.97
85007 264 217 $436.44
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 102 77 $414.26
80185 86 57 $398.73
88142 100 96 $377.89
84145 26 26 $361.79
0320 126 103 $357.57
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 124 121 $341.33
82274 28 26 $335.51
93000 13 13 $321.67
87205 115 84 $277.57
J7060 5% dextrose/water (500 ml = 1 unit) 92 63 $232.25
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 654 496 $231.30
S0028 Injection, famotidine, 20 mg 264 215 $214.80
73501 14 14 $200.74
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 18 16 $171.16
80320 493 432 $170.54
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 42 41 $163.96
84443 Thyroid stimulating hormone (TSH) 12 12 $161.00
85652 85 81 $155.32
98960 89 63 $152.20
74018 13 12 $149.73
73140 13 13 $143.35
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 31 25 $139.38
0300 28 14 $114.17
88187 16 12 $111.96
81003 103 102 $92.48
82043 16 16 $89.21
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 15 12 $66.35
86780 13 12 $66.12
82540 16 16 $62.75
G0008 Administration of influenza virus vaccine 12 12 $53.06
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 53 25 $51.03
80329 517 427 $49.98
S5550 Insulin, rapid onset, 5 units 59 39 $48.22
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 16 12 $23.62
96415 15 12 $22.88
89050 23 13 $18.88
85008 15 15 $9.03
92557 25 24 $1.98
91300 12 12 $0.00